SNMC Analytics
Biopharma Strategy. Precision Analytics. Commercial Impact.
☰

Epidemiology Modeling & Market Sizing

Translating Epidemiology Into Strategic Insight

Forecasting team at work

We help biopharma teams build robust epidemiology models to inform commercial forecasts, support asset valuation, guide launch strategy, and underpin health economics and outcomes research (HEOR). Our work translates complex population-level data into clear, actionable insights that fit your organization’s decision-making needs.

What We Deliver

  • Global epidemiology models for incidence, prevalence, and treated populations
  • Detailed demographic mapping to capture the impact of population shifts on disease projections
  • Patient journey mapping for oncology, chronic diseases, and rare genetic disorders
  • Systematic literature reviews with expert triangulation and clear explanation of discrepancies across sources
  • Custom meta-analyses of peer-reviewed studies, tailored to the client's decision-making needs
  • Expert-guided assumptions for data-scarce or emerging indications

Why SNMC Analytics

At SNMC Analytics, we specialize in navigating the fragmented landscape of epidemiological data. We combine clinical rigor with strategic focus, drawing from global databases, peer-reviewed literature, and expert interviews to build models that withstand scrutiny. Our team has deep expertise in quantifying the effects of demographic trends, reconciling conflicting data through triangulation, and tailoring findings to your asset’s unique positioning, whether in early-stage planning or pre-launch readiness.